Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Tuparstobart by Incyte for Transitional Cell Carcinoma (Urothelial Cell Carcinoma): Likelihood of Approval
Tuparstobart is under clinical development by Incyte and currently in Phase II for Transitional Cell Carcinoma (Urothelial Cell Carcinoma). According...
Data Insights
Tuparstobart by Incyte for Solid Tumor: Likelihood of Approval
Tuparstobart is under clinical development by Incyte and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...